Should You Buy UiPath Stock Today? | PATH Stock Analysis
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 02 Jun 2026, 14:45 UTC
- Recorded by Tahlil Plus
- 02 Jun 2026, 15:04 UTC
AI-generated source summary
UiPath reported strong financial results exceeding guidance. ARR grew 12% year-over-year to $1.901 billion, with net new ARR of $49 million. The dollar-based net retention rate was 109%. GAAP gross margin was 82% and non-GAAP gross margin was 83%. GAAP operating income was $28 million, and non-GAAP operating income was $92 million. Net cash flow from operations was $132 million. The company's ability to maintain strong cash flow and profitability while investing in AI technologies positions it well for future growth. The stock is trading at a discount, with an intrinsic value of approximately $14.97 per share based on a discounted cash flow model, suggesting a potential upside from the current market price of $11.96. The company's performance indicates resilience and potential for continued growth in the AI automation sector.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.